Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
麝香壮骨膏 (Shexiang Zhuanggu Gao), also known as Musk Bone-strengthening Plaster, is an approved topical herbal plaster developed and manufactured by Chengde Jingfukang Pharmaceutical. As a Traditional Chinese Medicine (TCM) formulation, it is indicated for the treatment of rheumatism, musculoskeletal pain, and various bone and joint disorders. The product's therapeutic effect is derived from a blend of herbal ingredients, with musk (shexiang) serving as a key component. It functions by relieving pain and promoting local blood circulation at the site of application. While its clinical efficacy is recognized within the framework of TCM, its specific molecular targets and biological mechanisms have not been formally characterized in the context of modern pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 麝香壮骨膏.